Howard W. Robin
2011
In 2011, Howard W. Robin earned a total compensation of $3.2M as President and Chief Executive Officer at Nektar Therapeutics, a 29% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $650,000 |
|---|---|
| Option Awards | $1,732,530 |
| Salary | $785,131 |
| Other | $10,599 |
| Total | $3,178,261 |
Robin received $1.7M in option awards, accounting for 55% of the total pay in 2011.
Robin also received $650K in non-equity incentive plan, $785.1K in salary and $10.6K in other compensation.
Rankings
In 2011, Howard W. Robin's compensation ranked 1,988th out of 10,747 executives tracked by ExecPay. In other words, Robin earned more than 81.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,988 out of 10,747 | 82nd |
Division Manufacturing | 715 out of 3,958 | 82nd |
Major group Chemicals And Allied Products | 152 out of 1,031 | 85th |
Industry group Drugs | 85 out of 779 | 89th |
Industry Pharmaceutical Preparations | 71 out of 567 | 88th |
Source: SEC filing on April 30, 2014.
Robin's colleagues
We found four more compensation records of executives who worked with Howard W. Robin at Nektar Therapeutics in 2011.